1. Introduction
Bacteria adapt to different environments to survive changing conditions, and accordingly, they possess an enormous variety of protein kinases involved in signal sensing and transduction. For pathogenic bacteria, infection is ‘growth despite stress’, meaning adaptation to an often-poor metabolic substrate pool the host provides. The most well-described signalling cascades in bacteria are two-component systems (TCSs), which in general consist of a membrane histidine kinase that senses an extracellular signal, autophosphorylates a histidine residue and transfers the phosphate group to an aspartate residue of a response regulator or transcription factor [
1]. Ser/Thr phosphorylation, the major regulatory mechanism for cellular functions in eukaryotes, was identified much later also in bacteria [
2,
3], but it developed fast into an area of great interest due to its involvement in virulence. Ser/Thr kinases have been described in many bacteria, regulating a wide variety of bacterial functions, including glycolysis, protein translation, sporulation and, in pathogenic bacteria, also virulence and antibiotic resistance. Membrane-associated Ser/Thr kinases sense extracellular signals that lead to autophosphorylation and transfer of the phosphate to a serine or threonine residue of a target substrate. The phosphorylation here is not labile, and thus a phosphatase is necessary to remove the phosphate. Less frequently, tyrosine, arginine or cysteine phosphorylation by Ser/Thr kinases has also been described. Unlike TCSs, Ser/Thr phosphorylation integrates a complex signalling pathway in which many biological processes are involved [
4,
5]. This complicates considerably the study of its role. While the knockout of TCSs often produces a concrete phenotype in the cell, the knockout of a Ser/Thr kinase or phosphatase results in a pleiotropic phenotype in which different pathways are affected.
Recently, a Ser/Thr kinase (PknB, alternatively named Stk or Stk1) and its phosphatase (Stp) were characterised in
S. aureus [
6], a bacterium especially known for its ability to adapt to different environments and its resistance to many antibiotics.
pknB and
stp deletion and overexpression strains have been used to study their function in in vitro and in vivo experiments. Here,
S. aureus phenotypes, such as virulence [
7], antibiotic resistance [
8], cell wall synthesis [
9] and different omics, such as transcriptomics [
10], metabolomics [
11] and phosphoproteomics data [
12], were analysed to decipher the cellular functions that Ser/Thr phosphorylation regulates. The results revealed changes in the virulence, antibiotic susceptibility, cell wall composition and gene expression of
S. aureus. In
S. aureus COL and community-acquired MRSA (CA-MRSA) lineage USA300, PknB is a positive regulator of SigB activity for responses to heat and oxidative stress.
pknB deletion strains have been reported to have higher sensitivity to ß-lactam antibiotics but more resistance to Triton X-100- induced autolysis and to lysostaphin lysis. The reduced SigB activity increases the activity of the quorum-sensing global regulatory
agr-system resulting in the activation of
agr RNAII and RNAIII and
hla (α-hemolysin) virulence effector expression, while
spa (protein A) is downregulated. Moreover, a
pknB mutant is more virulent, as tested for a USA300 strain in mice [
8].
A number of metabolic enzymes (mainly in glycolysis) are phosphorylated by
S. aureus PknB, and its deletion affects the expression of genes that regulate central metabolic functions, such as nucleotide biosynthesis, cell wall metabolism and the citrate cycle [
6,
9,
10,
12]. According to these different studies and their phenotypic observations, e.g., growth behavior, colony formation and structural and biochemical information, in general the phosphatase Stp is the counter-player of the PknB kinase. Hence, a lot is known about the phenotype of these mutations; however, the metabolic effects of their combined knockout have not been determined yet, nor has anybody looked at the individual enzymes of
S. aureus primary metabolism and their detailed metabolic adaptation after the individual- or combined-knockout of Δ
pknB and/or Δ
stp. Direct metabolomics data on
pknB mutations are only available on cell wall metabolism [
11].
Hence, for our study presented here, genome-scale microarray gene expression data of
S. aureus NewHG in the late exponential phase were collected. To reveal systematically all pathway changes and obtain a full and far more sensitive view of all involved metabolic changes, we inferred bioinformatically metabolic flux changes from the transcriptome data comparing the wild type and mutations of kinase Δ
pknB, phosphatase Δ
stp or both Δ
pknBΔ
stp phenotypes. The transcriptome data constrained the inferred fluxes for the full metabolic network and allowed inference on all fluxes calculated, even if there was no significant gene expression change observed for a specific enzyme of the pathway studied. Although this is not a direct metabolite measurement, the prediction error is reduced by fulfilling all network constraints to 5–10% for individual flux predictions (validated in [
13] by measuring several metabolites). Further metabolic studies focusing on other carbon sources and growth time points can then build on the results presented here as a pilot study.
Our transcriptome data and the metabolic modelling show that there are many differences in peptidoglycan synthesis, amino acid catabolism and the glycolysis/gluconeogenesis route, while the flux modes calculated allow describing the flux changes for each enzyme of the whole network. To determine how much these mutation effects are (NewHG;
sigB+) or are not (
S. aureus NCTC 8325;
sigB−) strain dependent or change with different sampling points, we adapted our metabolic model and compared results to
S. aureus NCTC 8325, for which gene expression data [
10] on the key comparison
pknB mutant versus the wild type are available for the mid-exponential phase. Further, we used interactome data to correlate our results with PknB/Stp in phosphorylation data on cell wall biosynthesising enzymes (Fem proteins) [
9]. Further analyses we present shows a clear and strong impact of PknB regulating metabolic adaptation in
S. aureus, the importance of the
yvcK/
glmR regulon and the
cdaA operon in these processes and delivers after phylogenetic comparisons detailed structure models of the
S. aureus GlmS protein and GlmR riboswitch.
2. Results
The
S. aureus NewHG phenotype was analysed using the wild-type as well as isogenic mutant strains with deletions of the kinase (
pknB), phosphatase (
stp) or both (
pknB and
stp). Strain NewHG (also called NewmanHG) is a highly virulent isolate [
14], in which the point mutated global virulence regulator
saeS in strain Newman is repaired [
14]. In contrast, strain NCTC 8325 [
10] carries a functional mutation of the alternative sigma factor
sigB due to a mutation in the regulatory
rsbU gene and a second mutation in the regulatory gene
tcaR [
15]. We chose NewHG as a background strain due to its high virulence properties and its functional
sigB operon important during stress response. In consequence, we could compare different strain backgrounds, a virulent and a less virulent
S. aureus strain. First, analysis involved transcriptome analysis of 2414 genes in strain NewHG (
Figure 1 left, top; based on the
S. aureus Newman genome). Genes that were expressed significantly higher or lower are all listed in
Table S1, and specific virulence factors are listed in
Table S2 (see for both
Supplementary Excel File S1).
Supplementary File S2 shows the SBML model.
Table S3 in Supplementary File S3 compares the enzyme activities of each mutant compared to the wild type, and
Table S4 gives the curated NewHG gene expression raw data of the transcriptome measured. All data used in this work, including the Ser/Thr kinase wild type and mutations of kinase (
pknB), phosphatase (
stp) and double mutant, have been deposited in the GEO repository (accession no. GSE122362). The reference data GSE15346 used for comparison are also available from GEO [
10]. The computational flux model using the software YANAvergence is given with a stochiometric matrix (
Table S11 in Supplementary File S8), solution space (
Table S12 in Supplementary File S9) and successful convergence for the wild type and mutants (
Figure S2). Detailed strain comparisons are given for gene expression data (
Tables S5–S7 in Supplementary File S5) and the genome (
Tables S8–S10 in Supplementary File S6). In addition, gene identifiers are listed in the
supplement (Table S13 in Supplementary File S10). More information regarding
glmR conservation has been described in the
supplement (Supplementary Material).
The collected gene expression data indicate significant deregulated expression of several enzymes in the mutant strains compared to the wild type, but for inference of the metabolic fluxes, the complete enzyme network was meticulously set up. We used pathway information from public databases (KEGG) for
S. aureus NewHG, and we corrected the list of the enzymes available for NewHG by sequence analysis of the genome sequence and by adding or modifying enzymes as apparent from this analysis (
Figure 1 left, middle). Next, the set of pathways available for this enzyme network was calculated using the software YANA (suppl2_SBMLS1.sbml gives the model in SBML/XML format). The software YANAsquare estimates pathway strengths: For this, the directly measured gene expression data (
Figure 1 left, bottom) are mapped to the pathways, and gaps or missing pathway information are interpolated for the network. The estimated metabolic flux distribution is then step-by-step adapted to minimise the calculation error using the software YANAvergence. The complete flux distribution for the whole network was calculated. In this way, the pathway fluxes were inferred from the transcriptome data and results are shown in
Figure 2 and
Figure 3. All elementary modes calculated are given in
Table S3 and, major flux changes inferred from the transcriptome data, repeated and found in both experiments, are summarised in
Supplementary Material Overview.doc, Table S14. Detailed quality controls in
Supplementary Material Figure S2 for wt, Δ
pknB, Δ
stp and Δ
pknBΔ
stp) indicate the relative changes for the different mutants compared to the wild type. Predictions for expression changes of virulence factors were independently validated by qRT-PCR (see
Supplementary Material Overview.doc, Table S15).
To investigate how general our model is with its estimated flux changes, we next analysed the effects of a
pknB knockout in a second
S. aureus strain NCTC 8325 versus the wild-type control (
Figure 1, middle). We performed similar calculations for this independent transcriptome dataset and different
S. aureus strains to infer here also metabolic fluxes (genome comparison:
Tables S8–S10 in Supplementary File S6; comparative condensed reaction model in
Table S11, Supplementary File S8; extreme pathways for NewHG in
Table S12, Supplementary File S9; array and gene identifiers in
Table S13, Supplementary File S10; strain comparison of fluxes in
Table S14 in the Supplementary Material Overview.doc). Note that the metabolic model used was the same for both strains; however, the transcriptome data are strain specific and independent transcriptome datasets for each mutant. For example, different values are presented for EPMs 14–16 comparing NewHG and its pknB mutant. Further independent evidence from other experimental data was considered (e.g., [
9]), and protein–protein interaction analysis compared also
pknB knockout in
S. aureus NewHG to the wild type. Together, all these data confirm the effect of
pknB regulation on peptidoglycan structure biosynthesis, potentially with different preferences of carbon use, which helps
S. aureus to switch between the pathways, depending upon the available nutrient source. Apart from that, we could identify growth conditions and strain-specific differences with metabolic modelling analysis and showed in detail the effects of counter-regulation by Stp and in the combined-knockout strain.
The role of the
yvcK/
glmR regulon and the
cdaA operon turned out to be important for this adaptation and was investigated closely (
Figure 1, left). The analysis also included the interactions between the regulatory proteins GlmR (
Figure 4) and CdaA and PknB involved in metabolic regulation, direct metabolic interaction (interactome analysis; but also known from the classical operon and regulon models;
Figure 4 and
Figure 5) as well as phosphorylation of GlmR.
Figure 5 shows the cell wall metabolism regulated by
pknB, the
cdaA operon and the
ccpA regulon. Ultimately, we found highly conserved phosphorylation sites relying on strain-specific homology models from two GlmR crystal structures (
Figure 6A), and based on available sequence data, bioinformatics analysis was performed (
Figure 6 and
Figure 7). Furthermore, we compared
S. aureus GlmR-specific data with those of other Gram-positive bacteria by using alignments, homology models and phylogenetic trees of regulatory structures. Moreover, we analysed the structure of the GlmS riboswitch (a self-cleaving ribozyme) in
S. aureus strain NewHG.
2.1. Metabolic Modelling and Pathway Changes for pknB/stp Mutations
In our study, we used transcriptome data to predict metabolic changes by modelling, as there are no direct metabolome data for the different genetic modifications available. We previously established the metabolic modelling method for
S. aureus under different growth conditions based on gene expression or proteome data [
20]. For example, in a
S. aureus pathway modelling study involving flux estimates for nucleotide and carbohydrate metabolism, the inferred flux predictions from gene expression data were subsequently validated and shown to be correct (+/− 5–10% in flux strength) by direct metabolite measurements of metabolite concentrations [
13]. The current study relies on the same method, and we approached the estimate of metabolic flux differences between three mutants with genome-scale gene expression data and minimised the calculated pathway deviations by network analysis. We further validated the metabolic network and flux activity differences found for two mutants (
pknB and
stp) compared to the wild type in another
S. aureus strain with a second dataset. Moreover, the phenotype observations on cell wall metabolism as well as protein–protein interactions directly measured in a recent publication are highly consistent with our calculated results [
9]. To derive a metabolic model of
S. aureus NewHG, first all enzymes of central metabolism according to genome annotation and hand curation were considered. A metabolic model not just looking at the textbook pathways but using all extreme pathways modes (EPM) was calculated from this. One such EPM balances all internal metabolites involved by the combination of its involved enzymes. The EPMs show all pure (“extreme”) pathways accessible for the system and provide hence a generating set to describe all real flux distributions by the combination of the EPMs. EPMs give increasingly detailed information than canonical metabolic pathways. However, they are not a 1:1 transfer of these, but rather EPMs cover often only several enzymes of a pathway. The sum of all EPMs allows considerably more flexibility and better metabolic buffering than just the textbook pathways could suggest. Precisely for this reason, such an analysis is important to better understand the high metabolic adaptation capabilities of NewHG and the detailed effects of
pknB or
stp mutation on metabolism. The calculated flux strengths used the information from gene expression data as an approximation for the flux strength. This is possible, as the network and the flux strength calculation even out errors in the individual estimates (similarly all enzymes in the same EPM must be balanced), so low changes in fluxes can also be detected (down to just 5%).
The metabolic model [
20] was hence extended to include cell wall metabolism, in particular peptidoglycan synthesis. The different pathways were all given in sufficient detail to investigate the complex changes in enzyme activity according to the gene expression data. Different flux modes were obtained for the metabolic model. The network input file (with the detailed stoichiometric matrix) can be viewed as SBML S1 in SBML/XML format. In total, 149 reactions were taken into consideration, including central carbohydrate, amino acid and lipid metabolism, nucleic acids and peptidoglycan pathways. Next, all balanced metabolic pathways involving this set of enzymes were calculated, which resulted in 87 extreme pathways; reactions and modes are listed in the
supplement (Table S3). In particular, the flux balance analysis allows revealing hybrid pathways shared between two or more canonical pathways. We wanted to investigate next the differences in pathway activities under wild-type and mutant conditions. For this, the gene expression data (GSE122362) were mapped on the pathway modes and an optimal fit was calculated using YANAsquare and the fast convergence routine YANAvergence.
Figure 2 visualises the resulting pathway changes and activities for the three mutant strains of NewHG compared to the wild type (for detailed activity values of the entire pathways, see
Table S3 in Supplementary Excel File S3). This compact figure is a pathway graph, and higher and lower activities compared to the wild type are shown according to the extreme pathways calculated. On the y-axis, the activity change is calculated, and no change corresponds to the middle position. This is a calculation from flux balance analysis according to the data provided; hence there is no
p-value given, and the log2 fold-change values (log2FC) are directly calculated according to the network topology. Sensitivity according to metabolite control measurements shows that a 10% change (sometimes even 5%) for a pathway can still be detected by our flux analysis (Cecil et al., 2015) [
13].
Table 1 gives an overview on the complex results, and
Figure 3 summarises all in a biochemical pathway map (next section). Positive values indicate significant upregulation of this pathway in the corresponding mutant,
pknB,
stp or double mutant. The three strains thus do not change the metabolism in the same way, though the effects of
pknB and the double knockout of the kinase and phosphatase mutants are similar for many pathways. On the x-axis, the number of the extreme pathway modes are listed. Each number represents one extreme pathway from our calculation, usually a modification from a textbook pathway, and the specific enzyme combinations for each pathway for NewHG are listed in
Table S3 (Supplementary Excel File S3), and flux activities compared for NewHG and NCTC8325 are shown in
Table S14 (Supplemental Material Overview.doc). The pattern shows that some pathways change strongly, while most others change only in the medium-to-moderate level. The biggest negative peak is caused by the regulation in glycolysis and is strongly different. As we can clearly see from
Figure 2, most of log2FC values are still close to 0, which indicates these pathway fluxes remain relatively constant in the three mutants compared to the wild type. This observation also implies the rate that is only marginally different by the loss of either PknB or Stp. Instead, the obvious changed modes are 57 (transaminase reactions), 50/51 (upper glycolysis and PTS) and 10/60/63/65/70 (amino acid metabolism).
Table 1.
Significantly up- and downregulated pathways in S. auerus NewHG, pknB and stp mutants 1.
Table 1.
Significantly up- and downregulated pathways in S. auerus NewHG, pknB and stp mutants 1.
Pathways | Metabolites | Effect on (Fold-Change) |
---|
Summary | ΔpknB/WT | Δstp/WT | ΔpknBΔstp/WT |
---|
Peptidoglycan synthesis (modes 83, 85) | - | + GlcK (1.5) −aa | + GlcK (1.5) −aa (2.8) | + GlcK (1.5) −aa (1.8) | + GlcK (1.5) −aa (2.5) |
Pyrimidine synthesis (modes 55, 66, 59) | - | | NA | + PTS (1.78) −GlcK (1.8) | −aa −GlcK (1.6) |
Purine synthesis (modes 54, 56, 60, 65, 67) | - | | + (2.2) | + (1.4) | + PTS (5.5) −aa (13.3) |
Nitrogen metabolism: Phe, Tyr, Gly, Glu and Arg metabolism (modes 46, 47, 4, 8, 12, 19, 83, 20, 49, 53, 20, 36, 37, 43, 62, 64, 70, 63, 69, 61) | Phe | + GlcK −aa | + GlcK (3.1) −aa (6.2) | + GlcK (1.9) −aa (2.6) | + GlcK (3.3) −aa (5) |
Tyr | | + PTS (2.1) −GlcK (2.1) | + aa (2.9) −GlcK (3.8) | + PTS (1.7) −aa (2.1) |
Gly | - | - | - | - |
Glu | + aa (>30) | + aa (47.5) | + aa (32) | + aa (55.5) |
Arg | | −Gln (2.2) | NA | NA |
Glycolysis (mode 50) | PTS Glc → Pyr | - | −3.3 | −1.5 | −4.1 |
GlcK Glc → aKG | - | −4.2 | −3.3 | −12 |
2.2. Detailed Analysis of the Pathway Results
After analysing the significantly altered pathways, we created a more detailed list of the metabolic features that changed in the mutants (
Table 1; EPM denotes the calculated extreme pathway mode): peptidoglycan synthesis (EPMs 83, 85), nucleotide synthesis (purine and pyrimidine; EPMs 54, 56, 58, 60, 65, 67, 55), aromatic amino acid synthesis (tyrosine, EPMs 61, 63, 69; phenylalanine EPMs 62, 64, 70), amino acid catabolism (threonine, EPMs 10, 11; glutamate, EPM 51; glutamine, EPM 43; aspartate, EPM 57), and pyruvate metabolism (EPM 44) (
Table S3 in Supplementary File S3).
Table S14 in Supplementary Material Overview.doc provides a detailed list of these pathway changes, enumerating the individual enzyme pathways, comparing mutant
pknB to the wild type in both strains. These data show that the textbook pathways for primary metabolism, such as glycolysis, pentose phosphate cycle and others, do not dominate the adaptation of
S. aureus. Moreover, the involved enzymes of one pathway, particularly regarding amino acid metabolism, are not always regulated together up or down at the same time. Instead, metabolic adaptation to PknB-dependent phosphorylation or a lack of phosphorylation causes joined enzyme pathways that are combinations of the well-known textbook pathways of primary metabolism to be up- or downregulated. In general, it was observed that either up- or downregulation of several central pathways is affected by a flux change in concerted metabolites. This is illustrated in
Figure 3, which indicates the central metabolism that is influenced by
pknB and
stp mutation. The corresponding textbook pathways and all major EPMs that involve enzymes of specific pathways affected by the deletion are shown as up- (green) or downregulated (red) compared to the wild type. In particular, the pathways for peptidoglycan, nucleotide and aromatic amino acid synthesis and catabolism involving aspartate transaminase in the double mutations display higher activity compared to the wild type, while others such as glycolysis are significantly stronger in the wild type. Interestingly, pyrimidine synthesis is dramatically impaired by
stp and the double mutation, but not by the
pknB mutation. Since the whole network is not yet completely described, we can only refer to the data we obtained. Indeed, there is a lack of knowledge of which proteins are solely phosphorylated by PknB and dephosphorylated by Stp. Interestingly, phosphoproteome studies show that a number of proteins are still phosphorylated on Ser/Thr residues in a PknB knockout mutant, although PknB is the only known Ser/Thr kinase in the strains used. Moreover, textbook pathways such as pyrimidine synthesis are not one-to-one related to the EPMs. Instead, several EPMs do involve several enzymes of the textbook pyrimidine synthesis and hence contribute, but none of the EPMs covers it completely. For example, regarding the pyrimidine EPMs for the
pknB mutant, e.g., 55 and 66, are rather simple modes, which agrees with the simple statement on pyrimidine metabolism, i.e., PknB mutation illustrates a similar flux activity in pyrimidine metabolism to the wild type; however, the Stp knockout shows rather individual differences between the modes. EPM 56 is a combination of different pathways, and there are more other enzymes involved (27 enzymes compared to 20 enzymes), so it shows relatively more variation compared to EPMs 55 and 66. Hence, there are clear individual differences for EPMs 55, 56 and 66.
PknB is clearly involved in the regulation of cell wall synthesis but also in numerous other metabolic pathway activities. It switches on, quite specifically, several pathways involving glycolysis (EPMs 50-52), but certain transaminase involving pathways are switched off (EPMs 57, 62–65). Stp, the phosphatase, takes away phosphate groups, mainly from the PknB phosphorylation but also from other proteins (
Figure 3, middle). This picture of the Stp phosphatase function is clearly a simplification based on the collected data: Firstly, the metabolic modelling results show that it can only partially antagonise PknB according to our pathway flux activity comparison between different mutants. It is important to observe that this only partial antagonising effect on PknB-regulated pathways suggests that further kinases/phosphatases may be involved (see the Discussion section). The highly complex network leads to fast adaptation to different environmental conditions, and the
pknB/stp regulatory system is not a Boolean on/off system but rather fine-tunes several pathways. Therefore, we could observe some opposite effects in the kinase and phosphatase mutants. A recent identification of more than 3000 phosphosites localised on Ser and Thr indicates that Ser/Thr kinase signalling, and activity are much higher than previously anticipated [
21].
For optimal adaptation of
S. aureus to changing environmental conditions, there are different routes to produce the same metabolite and, therefore, there are different extreme pathways in which the products are the same. This is the case for peptidoglycan, nucleotide and aromatic amino acid synthesis. Based on the estimated activities, the results reveal that some pathways producing each of these molecules have more activity than the wild type, while others have less. The main difference between these alternative routes is using glucose as a carbon substrate through the glucokinase enzyme (GlcK) or phosphotransferase system (PTS) or not using glucose at all by increasing the amount of aspartate as a substrate through aspartate transaminase (AST/GOT) (
Figure 3). However, there is not a clear tendency of specific mutants to activate or inhibit the use of glucose to produce these essential cell components. The observation that pyrimidine synthesis pathways when compared to the wild type are not different in the
pknB mutant, whereas they are severely impaired in the
stp mutant, indicates that only
stp is highly involved in pyrimidine metabolism.
Our observations suggest that the glycolysis pathway from glucose to pyruvate (EPM 44) is less active in the three mutants when compared to the wild type. In contrast, the glutamate synthesis pathway from aspartate and α-ketoglutarate to glutamate and CO
2 (EPM 57) is the most upregulated pathway in the three mutants. In addition, the reactions from glucose and glutamate to aspartate and α-ketoglutarate (EPM 51) as well as from glutamine and ornithine to arginine and α-ketoglutarate (EPM 43) are downregulated in the two single mutant strains, as well as in the double mutant. Unfortunately, we do not know the exact phosphorylated substrate yet; however, this observation clearly describes the correlation between the glutamate/α-ketoglutarate flux to the mutant strains. Interestingly, two other pathways were affected, comprising just two reactions for transforming threonine into glycine as a common step, followed by the reduction of the coproduct acetaldehyde to ethanol (alcohol dehydrogenase) or oxidation to acetate (aldehyde dehydrogenase). These are EPM 10 and EPM 11 pathways. These amino acid pathways are downregulated in the three mutants and give a clear hint that acetate and glycine are used to synthesise threonine. In
Table S3, negative enzyme activity values are displayed for EPM 11. This indicates that the fluxes for this EPM 11 operate in the opposite direction compared to the other EPMs.
In conclusion, the concerted changes allow direct and rapid adaptation to different environmental conditions, several pathways always allow the synthesis of required primary metabolites and enzyme pathways are often jointly reprogrammed by the action of kinase PknB or phosphatase Stp.
2.3. Validation of the Inferred Metabolic Responses and Gene Expression Changes in a Second S. aureus Strain
For the above dataset, the flux calculations and gene expression data show that PknB is instrumental in the adaptation to different carbon sources. However, it is not clear whether conclusions regarding the metabolic adaptations that we observed and then translated into flux values can be generalised for S. aureus.
To test this, we used data from a knockout strain in the gene
pknB, compared to the wild type, but considered a different
S. aureus strain NCTC 8325 as the control. In this case, the samples for gene expression analysis were taken from an earlier time point of the exponential growth phase (GEO dataset GSE15346) [
10]. We first tested by detailed genome comparisons between a reference
S. aureus strain (COL), strain NCTC8325 and Newman, the background strain of NewHG used in this study, whether there are strain-specific differences in the encoded proteins. The metabolic enzymes of primary metabolism are identical among all three strains. There are just two differences from the reference strain COL, looking at NCTC 8325 and NewHG regarding the metabolic enzymes: succinyl-diaminopimelate desuccinylase is absent, and teichoic acid synthesis enzyme SACOL1043, the glycosyltransferase TarM, is specifically present in the COL strain. However, there are a few other protein differences between NCTC 8325 and NewHG that may impact regulation (for strain-specific genes, see
Tables S8–S10).
The calculation of the stoichiometric matrix is shown in
Table S11 in plain-text format and in SBML format in the file suppl2_SBMLS1. sbml for computation. The resulting extreme pathway modes are given in
Table S12. This computational result uses
Table S11 as an input file with YANAsquare software and demonstrates there is no difference, as the central metabolic enzymes are the same in NCTC 8325 and NewHG, making the data of GSE15346 [
10] an ideal dataset for such a comparison. To achieve a better comparison, the data of the old
S. aureus NCTC 8325 microarray design (Scienion, Berlin, Germany) were mapped against the identifiers of the new microarray design (Agilent, Palo Alto, CA, USA) in this study, applied in the NewHG study presented here (
Table S13). The summarised results for major pathways are shown in
Table 2 and are listed in detail in
Table S14. Thus,
pknB mediates amino acid synthesis and strengthens fluxes for this; however, the flux in glycolysis is overall only slightly impaired in both the
pknB mutation
S. aureus strains compared (7.1% in NewHG and 6.7% in NCTC 8325;
Table 2; details in
Table S14). The different elementary modes are listed, as well as the calculated metabolic flux strength in NewHG and in NCTC 8325.
Nevertheless, looking at the inferred pathway differences, the full individual variation between both experiments becomes obvious. Overall, a clear tendency is visible by stronger glycolysis as well as anabolic amino acid metabolism in the NCTC 8325 dataset mediated by PknB. Predominantly, the overall contrasts for central carbohydrate pathways, amino acid metabolism and lipid metabolism are fully supported by this second dataset. A concerted metabolic change in fluxes was observed in both datasets (
Table 2). The pathways for nucleotide synthesis, aromatic amino acid synthesis and catabolism involving aspartate transaminase (AST), also known as glutamic oxaloacetic transaminase (GOT), were less active in the
pknB-knockout strain. There are still some strain-specific adaptations upon
pknB-knockout mutation, e.g., the pentose phosphate pathway is severely impaired by the absence of PknB in NewHG but not in NCTC 8325. We think that this is due to strain-specific differences. In particular, NCTC 8325 is defective in the alternative sigma factor B and has also other genome differences. However, the exact mechanism for the observed difference in the regulation of the pentose phosphate pathway is not known.
Amino acid metabolism is similarly regulated between NewHG and NCTC 8325; for glycine, there are clear differences. Apart from strain-specific differences in metabolic regulation, some observed differences in gene expression might also be caused by the sampling time point. Though the metabolic activity changes, the central metabolism and amino acid metabolism induced by pknB mutation remain highly identical in both S. aureus strains.
We also considered further available data, in particular protein–protein interaction data, comparing
pknB knockout in
S. aureus NewHG to the wild type. Another impact of PknB is highlighted by this analysis (and supported by the detailed experimental investigation in [
9]): PknB promotes peptidoglycan synthesis. This is also observable from the metabolic modelling of the first dataset above, which suggests that the extreme pathway modes for cell wall synthesis are strong in the wild type and impaired in the
pknB-knockout mutant and could be supported by these data (
Table 3) as well as the predicted fluxes from central metabolism contributing directly to cell wall growth.
2.4. Involvement of the glmR Regulon and the cdaA Operon
Our gene expression data and the metabolic model show the role of PknB in serine/threonine phosphorylation in amino acid catabolism and the switch between glycolysis (glucose as a substrate) and gluconeogenesis (aspartate as a substrate) to synthesise different cell molecules, such as peptidoglycan, nucleotides and aromatic amino acids. Thus, PknB/Stp modifies the carbon fluxes and cell wall synthesis fluxes.
However, studies from Gram-positive (e.g.,
B. subtilis and
M. tuberculosis) reveal different regulatory proteins that are involved in this switch. The carbon storage regulator (CsrA), a well-studied protein mainly in Gram-positive bacteria, such as
M. tuberculosis, regulates the central metabolism (activates glycolysis and inhibits gluconeogenesis) by affecting the stability of mRNAs. CsrA also controls other aspects, such as cell surface properties, motility, quorum sensing, virulence and interactions with animal and plant hosts [
22]. Despite these similarities to
pknB/stp mutant phenotypes, the
csrA gene does not exist in
S. aureus. The second candidate is YvcK, a less well-studied protein that used to be labelled in
S. aureus as a hypothetical protein (NCBI accession no. BAF67006) but was recently identified as GlmR in
B. subtilis [
23]. This protein is essential for bacterial growth under gluconeogenic conditions in
B. subtilis,
L. monocytogenes [
19] and
M. tuberculosis. In
B. subtilis, GlmR is important for the regulation of carbon partitioning between central metabolism and peptidoglycan biosynthesis [
23]. In addition, it is also known to be phosphorylated by a serine/threonine kinase in
B. subtilis [
16],
L. monocytogenes and
M. tuberculosis. Thus, it represents a promising candidate to bridge the serine/threonine phosphorylation to switching between glycolysis and gluconeogenesis.
The metabolic flux effects (flux data: see
supplement; inferred from the gene expression data of
S. aureus) are best condensed into the following model (
Figure 5) on the function of the
glmR/
yvcK regulon in
S. aureus as
glmR (GlmR transcriptional regulator) and
glmS (L-glutamine-D-fructose-6-phosphate aminotransferase): central for this operon is a gene cassette comprising
yvcJ (RNase adaptor),
glmR/
yvcK and
whiA (transcription factor). The alignment profile comprising of
B. subtilis,
S. aureus,
L. monocytogenes and
M. tuberculosis is shown in
Figure 6B and of GlmS ribozyme structure in
Figure 5. In addition, a couple of different accessory genes located either upstream or downstream are found in other bacteria around two neighbouring operons:
sigW-
rsiW and
cdaA-
cdaR-
glmM-
glmS in
B. subtilis [
23]. The
whiA,
yvcK and
yvcJ genes are highly conserved in different species, which suggests they are core genes of the
glmR/
yvcK regulon that mostly act in a coordinated manner.
The metabolic modelling data suggest that proteins encoded by the
glmR/
yvcK regulon and the
cdaA-
cdaR-
glmM operon might be important mediators of the PknB-regulated adaptation (
Figure 1, analysis flow) and were investigated more closely. The interactions between these regulatory modules and PknB involve metabolic co-regulation, as well as direct metabolic interaction via the GlmS riboswitch that binds glucosamino-6-phosphate (
Figure 5).
2.5. Detailed Interaction of PknB with GlmR
An interactome analysis (
Figure 4) predicted according to the database (see the Materials and Methods section) that several direct substrates of PknB interact with GlmR [
14,
24], and GlmR stimulates the activity of GlmS [
23], as well as cell wall metabolism proteins. The model is based on known protein–protein interactions, including information from databases such as STRING, experimentally proven interactions between cell wall synthesis enzymes [
9] and metabolic interactions (as changing a metabolic pathway). Moreover, we suggest that GlmR may be a direct substrate of PknB, as has been shown in
Streptococcus pyogenes [
25,
26]. In
B. subtilis, the sequence homologue Ser/Thr protein kinase PrkC acts as a substrate for phosphorylation of GlmR, which plays an important role in cell morphogenesis [
16]. In
S. aureus, it has been shown that PknB (also known as Stk1) plays a role in the regulation of cell wall biosynthesis and in drug susceptibility [
27]. In
M. tuberculosis, PknB-mediated phosphorylation with various substrates has been shown [
28], and based on sequence, structure and function conservation, we predict GlmR can be indirectly involved in these phosphorylation events in regulating cell shape and cell division. Therefore, we suggest a model, shown in
Figure 5, that explains how PknB contributes to cell wall metabolism in the presence and absence of preferred carbon sources. The observed tight metabolic co-regulation (transcriptome data, metabolic modelling; see the previous section) follows from the mutual regulatory interactions between PknB, the GlmR regulon and the
cdaA-
cdaR-
glmM operon (
Figure 5). This model is further supported by the genomic organisation of
pknB, the
cdaA operon and the
ccpA regulon. Expression of the
glmS gene can be stimulated by GlmR under a low-glucose condition or glucose depletion (see [
23];
Figure 5, middle). This regulation is governed by the carbon catabolite control protein (CcpA), and GlmR may appear abundant when CcpA activity is low [
9,
11]. As a result, GlmS is activated, so the system diverts more carbon sources to peptidoglycan biosynthesis (
Figure 5, right). However, the regulation may be more complex, since PknB may be capable of phosphorylating GlmR as a secondary regulation pathway, but this is only inferred from our transcriptome data, though supported by published data in other Gram-positive bacteria (
Figure 5, left). The resulting effect supports the notion that CcpA may have different isoforms [
29]. In addition, as observed by Patel et al. (2018) [
23] for
Bacillus subtilis, the carbon catabolite control protein CcpA represses genes for the use of non-preferred carbon sources when glucose is available, as well as the operon encoding
glmR (
yvcI-yvcJ-glmR-yvcL-crh-yvcN). As a result, GlmR should be most abundant when CcpA activity is low. CcpA repressor activity is indirectly stimulated by elevated levels of fructose-1,6-bisphosphate present during growth on preferred carbon sources. During growth on non-preferred, gluconeogenic carbon sources, GlmR will be more abundant, consistent with its role in diverting carbon to PG synthesis under these conditions. Furthermore, the authors proposed a model in which GlmR activates GlmS, and this activity is inhibited when GlmR is bound to the downstream metabolite UDP-GlcNAc. Further supporting experimental observations for the role of the
glmR/
yvcK operon in peptidoglycan synthesis are given in
Supplementary Material.
2.6. Conserved Sequence and Structure of GlmR
Genome sequence analysis revealed similarity in the conserved
glmR gene cluster in Gram-positive bacteria, including
B. subtilis,
S. aureus,
S. epidermidis,
Streptococcus pneumoniae,
Lactococcus plantarum and
Listeria monocytogenes (
Figure 6C). However, GlmR homologous proteins are not restricted to Firmicutes and can also be found in Actinobacteria (e.g.,
M. tuberculosis) and Proteobacteria (e.g.,
E. coli), as shown in the phylogenetic tree of
glmR (
Figure 6C). GlmR possesses probably a conserved UDP-sugar-binding site, as originally described in
B. subtilis [
18], which could also be found in
S. aureus strains Newman, NCTC 8325 and COL (
Figure 6B). These data support that fact that in
S. aureus, GlmR interacts with NAD, UDP-Glc and UDP-GlcNAc as it does in
B. subtilis, underlining its potential role in regulating cell wall metabolism. Noteworthy, the deletion of PknB in
S. aureus affects cell wall metabolism by accumulation of peptidoglycan precursors, including UDP-GlcNAc [
9].
Multiple sequence alignment (MSA) further confirmed the high conservation of the putative PknB phosphorylation site of GlmR. GlmR from
B. subtilis is known to be phosphorylated at Thr-304, as directly measured [
16]. In
S. aureus, Thr-304 could also be the target phosphorylation site, as shown in
Figure 6B (in MSA, the counting is different and shifts the threonine to position 338 in MSA).
The predicted ligands of GlmR were further analysed by 3D structure analysis. The GlmR/YvcK structure of
B. halodurans was directly determined by X-ray crystallography at 2.6-angstrom resolution (PDB ID: 2O2Z) [
30]. The the GlmR protein structure of
B. subtilis was recently modelled and its phosphorylation by PrkC studied [
18]. To model the GlmR structure in
S. aureus, we used the template crystal structure from
S. epidermidis ATCC 12228 (PDB ID:2PPV; at a high resolution of 2.0 angstroms) and the
B. subtilis crystal structure as a template and calculated homology models (see the Materials and Methods section) using the strain-specific
S. aureus Newman, NCTC 8325 and COL sequences (
Figure 6A).
S. aureus and
B. subtilis were predicted to be homodimers just like the template (high homology found), and the
L. monocytogenes structure could possibly be a monomer (data not shown) [
31].
Figure 6A shows that the identified residues could be involved in binding to UDP sugars, and we verified that these residues are conserved in many Gram-positive bacteria.
2.7. General Regulation of the glmR/yvcK Regulon
In addition to GlmR, the biosynthesis of peptidoglycan is tightly regulated by the participation of the
cdaA-
cdaR-
glmM-
glmS region of the chromosome. This module encodes the major cyclic-di-AMP synthase (CdaA) and a regulator of CdaA, CdaR. GlmS encodes an aminotransferase that catalyses the first reaction of peptidoglycan synthesis. The reaction involves conversion of fructose-6-phosphate (F6P) into glucosamine-6-phosphate (GlcN6P) using glutamine as an amino group donor. Upon stimulation by GlmR, GlmS allows the organism to use a non-preferred carbon source. The switch between the pathways can be regulated by cooperative activity of the
ccpA regulon and the
cdaA operon [
29]. This involves repression of CcpA, thereby increasing the concentration of GlmR and the ribozyme action of GlmS. The GlmS ribozyme has been shown to be present first in
B. subtilis [
17] and then in
S. aureus [
32]. Including these data, we calculated the conserved secondary structure of the GlmS ribozyme and show it in
Figure 5 (top-right corner). GlcN6P has been shown to induce the riboswitch in
S. aureus. However, the overall rate of the riboswitch is slow in
S. aureus as compared to other bacteria [
32].
The
cdaA operon centres around the diadenylate cyclase CdaA and controls peptidoglycan biosynthesis in
Lactococcus lactis [
33]. The modulatory effect was reported to come from GlmM. We complement these data here by adding that the whole module (
cdaA,
cdaR,
glmM, mannitol-specific enzymes and
glmS) is involved in the metabolism of cell wall synthesis in
S. aureus and tightly interacts metabolically with PknB and GlmR according to our metabolic model and reported protein interactions from the literature and databases (
Figure 4). A
glmR/
yvcK sequence homology analysis of a broad range of different microorganisms was used to classify the bacteria into the major clades of their phylum, i.e., Firmicutes (clade 1), Proteobacteria (clade 2) and Actinobacteria (clade 3) (
Figure 6C). The analysis included the genera
Streptococcus,
Staphylococcus,
Bacillus,
Listeria,
Streptomyces,
Salmonella,
Aggregatibacteria,
Escherichia,
Corynebacterium,
Pseudomonas,
Nocardia,
Micrococcus,
Streptomyces and
Mycobacterium. This demonstrates that GlmR/YvcK has evolved into a broad range of bacterial species living in highly diverse habitats. Moreover, they are characterised by different cell wall compositions, shapes and processes of elongation and cell division. Our phylogenetic tree relies directly on the original data, as established by sequencing. For the highest resolution, three
S. aureus strains were considered, as well as the
S. aureus consensus sequence. Furthermore, several other staphylococcal species were also considered.
Interestingly, we observed several bacteria lacking glmR/yvcK in their genomes, such as Neisseria, Haemophilus, Helicobacter and Chlamydia trachomatis. This suggests that there are possibly other alternative regulatory mechanisms present at least in some rod-shaped Gram-negative bacteria.
2.8. The pknB Operon Is a Regulatory Operon in Many Bacteria
The
pknB operon involves six genes in
S. aureus, but the only two genes present in the four microorganisms
S. aureus,
B. subtilis,
L. monocytogenes and
M. tuberculosis are
pknB and
stp (shown in
Figure 7B). The protein kinase gene is indicated as
pknB, and the downstream gene
stp encodes the corresponding phosphatase. The
pknB operon from
M. tuberculosis is considerably different from the other three according to the operon composition. It has unique genes that do not appear in the operons of the three other pathogens: a second Ser/Thr kinase (this is absent from the other microorganisms) and two genes responsible for the rod shape of the bacterium. Genes related to protein translation are present in the other three microorganisms, which have a gene
rpe encoding ribulose-phosphate 3-epimerase from the pentose phosphate pathway, another for starting DNA replication (
priA) and one gene for coenzyme A biosynthesis, involved in fatty acid and pyruvate metabolism. In addition, the
L. monocytogenes operon includes a gene for thiamine diphosphate synthesis, a vitamin B1 derivative that catalyses several reactions of the catabolism of sugars and amino acids (it is present in enzymes such as pyruvate dehydrogenase and decarboxylase, α-ketoglutarate dehydrogenase and transketolase). A detailed view compares the operons from
B. subtilis 168 and
S. aureus NewHG and NCTC 8325 (both strains) (
Figure 7C). This shows in detail similarities to
B. subtilis, such as the
glmS ribozyme, an RNA structure for the glucosamine-6-phosphate riboswitch ribozyme (
glmS ribozyme) in the 5′untranslated region of the
glmS gene mRNA, but close by, there is a clear difference of five genes conserved only in
S. aureus. These data on the impact of the preferred carbon source and
pknB in directing metabolism towards central metabolism or towards cell wall biosynthesis have major implications for understanding cell wall biosynthesis and methicillin resistance
2.9. Virulence Gene Expression and Metabolic Flux Changes Are Tightly Connected in S. aureus
Concerted action of the kinase PknB and its corresponding phosphatase Stp, together with proteins encoded by the
glmR/
yvcK regulon, may be important for optimal growth under harsh environmental conditions, e.g., glucose limitation or infection in the host. Besides its impact on metabolic functions, PknB/Stp is also involved in the regulation of virulence factor expression, which might play an important role in infection. Regarding virulence factor expression, we made several interesting observations (
Tables S1 and S2 in Supplementary File S1). Many virulence-associated genes are upregulated in the double mutant and
pknB mutant. In contrast, the
stp mutant illustrates the effect of downregulation in many virulence genes.
Toxins, including α-hemolysin (hla), β-hemolysin (hlb), γ-hemolysin components (hlgA, hlgB, hlgC), leucocidin toxin subunits (lukD, lukE, lukF, lukS), serine proteases (splA-F) and cysteine proteases (sspB, sspC), are upregulated in mutants lacking functional PknB. Thus, the expression of PknB downregulates the transcription of these well-known virulence factors.
In contrast, many virulence factors and their regulators (
agr,
sae) appear downregulated in the
stp mutant compared to the WT. Most strikingly, genes encoding proteases, such as serine proteases (
splB-
F), cysteine protease
sspB, hemolysins (
hlg,
hla), leucocidins (
lukD,
lukE,
lukF,
lukS) and immunomodulatory proteins (
chp,
scn,
sbi), are strongly downregulated in the
stp deletion strain. As stated above, many of these factors are upregulated in the
pknB mutant but also in the double-knockout mutant. These results strongly suggest the involvement of serine/threonine phosphorylation in the transcriptional regulation of virulence factors in opposite ways: the action of PknB might downregulate the expression of virulence factors, while Stp-dependent dephosphorylation leads to upregulation. Moreover, several regulators related to virulence factor expression are negatively affected by
pknB or
stp deletion, including ArlS (two-component sensor histidine kinase), SaeRS (two-component system response regulator, sensor histidine kinase regulator), Mgr (MarR family regulatory protein) and Sar (staphylococcal accessory regulator T, S, Y and R). This observation is in line with previous findings reporting that phosphorylation of SarA and MgrA modulates virulence and antibiotic resistance in
S. aureus [
34,
35].
2.10. qRT-PCR Validation of Gene Expression Data
To confirm the microarray results further, qRT-PCR experiments of selected genes were performed. We chose representative virulence genes for qRT-PCR analysis based on the high level of deregulation seen by us in the microarray study. We hence compared the expression of sspB, splB, hla and lip in the wild-type strain NewHG with the pknB and stp mutant strains. In the pknB mutant, expression was upregulated for sspB by 1.7-fold, splB by 1.3-fold, hla by 1.8-fold and lip by 2.1-fold. These data confirm the microarray results (see
Supplementary Material Overview.doc, Table S15). Moreover, in the stp mutant, there was corresponding downregulation: sspB by 5.1-fold, sspB 3.9-fold, hla 1.5-fold and lip 2.3-fold.
3. Discussion
In this study, we assessed the metabolic phenotypes and the effect of regulation on physiological functions in
S. aureus, controlled by
pknB/
stp during
S. aureus adaptation to infection. To achieve that, we used direct transcriptome data (strong in identifying direct regulatory effects and adaptations) as well as metabolic modelling based on extreme pathway calculations from these
pknB/
stp mutants’ transcriptomics (revealing more subtle changes mirrored in changes in pathways and inferred enzyme fluxes). No direct metabolite measurements were performed. Overall, we observed differences in the glycolysis/gluconeogenesis pathways leading to nucleotide, aromatic amino acid and peptidoglycan synthesis. Based on these results that match with those of previous studies [
6,
9,
10,
11], we proposed two regulatory modules that might be interacting with PknB/Stp in
S. aureus: the
glmR/
yvcK regulon and the
cdaA-
cdaR-
glmM-
glmS module. Furthermore, we analysed the sequence, structure and phosphorylation site conservation of the
glmR/
yvcK regulon among different microorganisms and suggested the complex interactome of PknB/Stp, including the previous regulatory modules. Finally, we used transcriptomic data to evaluate the virulence factors controlled by PknB and Stp.
The bioinformatics approach used in this study to infer different metabolic flux activities and to compare different conditions and strains in silico has proven reliable and efficient in former studies [
13,
15,
36]. Nevertheless, validation preferably with direct measurements of metabolites and enzyme activities should be included to predict cellular functions. However, such data are difficult to obtain, and the use of large datasets, e.g., from transcriptomics or proteomics, is valuable to draw reliable conclusions on the role of individual proteins in cellular functions. In general, the actual enzyme activity within the bacterial cell underlies regulation on a transcriptional, translational and post-translational level. Moreover, it can be further modulated by allosteric effectors. However, all these different effects of the inherently complex regulation must be sufficiently balanced for different enzymes acting in a network or pathway context to avoid shortage or accumulation of different metabolites. This network-balancing condition allows inferring metabolic fluxes with reasonable accuracy (about 5–10% for individual enzymes, as calculated in studies with direct metabolite measurements or metabolomics) [
13].
Here, we hence modelled the metabolic difference in cellular pathways, as estimated by flux balance computation based on transcriptome data of S. aureus wild-type strains and strains lacking the Ser/Thr kinase PknB, the corresponding phosphatase Stp or both proteins. The differences observed in the strains imply that the carbon source diversion may be governed by GlmR/YvcK expression. Furthermore, the data suggest that regulation occurs together with CcpA and PknB under a growth condition of low glucose concentration. To strengthen this hypothesis, we applied a secondary dataset of previously published data from a different S. aureus strain (NCTC 8325). The metabolic flux estimation results confirm that the metabolic effects caused by the pknB mutation are highly similar also in this strain. Since strain NCTC8325 does not express the alternative sigma factor SigB, we concluded the regulatory role of PknB and GlmR on both carbon source diversion and peptidoglycan synthesis independent of the expression of SigB. However, we noticed that the regulation caused by stp mutation shows more differences, which remain to be investigated further. Possibly, other so far unknown phosphatases are also involved in this regulatory network.
Regarding metabolic adaptation mediated by pknB in
S. aureus and implications for virulence, in the first study using
S. aureus strain NCTC 8325, several transcriptional changes were observed in a pknB mutant of this strain, which affected genes involved in purine and pyrimidine biosynthesis, cell wall metabolism, autolysis and glutamine synthesis [
10]. Most of these pathways were also affected in the present study using strain NewHG, a genetically modified version of strain Newman to obtain a more virulent strain. It shares virulence features with highly virulent clinical isolates (see Herbert et al., 2010 [
15]). The inclusion of strains lacking the phosphatase Stp and a strain lacking both activities allowed now a more comprehensive analysis to model growth dependent on the availability of different substrates, which may reflect infection conditions where more specific virulence factors are activated. The metabolic model is made fully available and provides by its extreme pathways (and their flux combinations) all pathways accessible to
S. aureus for the strain NewHG.
The comparison of each pathway activity between the wild-type strain and the three mutants suggests that Ser/Thr phosphorylation regulates somehow the switch between glycolysis and gluconeogenesis to provide the cell with enough cell wall components, nucleotides and aromatic amino acids. Ser/Thr phosphorylation/dephosporylation in
S. aureus is complex. There must be other mechanisms active other than Ser/Thr phosphorylation by the Ser/Thr kinase PknB and the Ser kinases HprK and RsbW. Moreover, cross-talk with two-component regulatory systems has been described [
21]. This highly complex network leads to fast adaptation to different environmental conditions, and the PknB/Stp system is not an on/off Boolean system but rather fine-tunes several different pathways. Therefore, we could observe clear opposite effects in the kinase and phosphatase mutants, as expected, but also unexpected similar up- or downregulation in all mutant strains. Thus, using flux balance analysis, we see that the flux of EPM57, which is the connection between glutamate to α-ketoglutrate, changes significantly for both the pknB mutant and the stp mutant; however, we do not know the exact phosphorylated substrate yet. In this study, we reported this change and how they are correlated clearly to the mutants. We believe the topic needs to be further investigated in the future.
The altered pathways are also directly related to the catabolism of different amino acids, including aspartate/glutamate, glutamine and threonine catabolism. It is known that
S. aureus survives through the catabolism of a secondary source and it encodes pathways to catabolise multiple amino acids, including those that generate α-ketoglutarate and oxaloacetate [
37]. Moreover, previous studies have proved that preventing the biosynthesis of oxaloacetate in the TCA cycle and its later conversion to phosphoenolpyruvate that is used in gluconeogenesis stops the synthesis of capsule precursors affecting
S. aureus virulence [
38]. In another study, the most virulence-attenuated
S. aureus mutants identified in a murine model of systemic infections mainly corresponded to defects in metabolism, such as aspartate and pyrimidine biosynthesis and the α-ketoglutarate/malate symporter [
39]. Expression of virulence genes, such as hemolysins and proteases, is modulated by PknB expression, as shown in
Table S3 in Supplementary File S3. Probably, this is due to rather affecting global regulatory systems, such as the
agr and
sar regulators, than direct phosphorylation/dephosphorylation of the virulence proteins. Although both datasets support the main conclusions described above, differences also became clear comparing both experiments and datasets: other EPM activities including secondary metabolites appear relatively different in the comparison of NewHG and NCTC 8325. This may be caused by the different sampling time points or action of the alternative sigma factor SigB, which is not expressed in NCTC 8325. In NCTC 8325, the sample was obtained at the middle exponential phase [
10], and in NewHG, it was obtained at the late exponential phase. However, the carbon usage preference governed by PknB remains the same in both strains. It may seem surprising that the carbon use was the same in a comparison of the mid- and late exponential phase. However, we did not compare full medium growth but rather we used a glucose-poor medium (B-medium; see the Materials and Methods section), where the bacteria have to use amino acids to support carbon metabolism [
37]
S. aureus encodes pathways to catabolise multiple amino acids, including those that generate pyruvate, 2-oxoglutarate and oxaloacetate. Obviously, there was no limitation regarding recycling amino acids in the late exponential phase compared to the mid-log phase for these pathways. This is also evident from the unimpaired growth curve (
Supplementary Material Overview.doc, Figure S1).
In addition, we applied different levels of constraints for the two strains: there are more enzyme activities derived from the gene expression values of NewHG, than NCTC 8325, due to the older design of the NCTC 8325 microarray (2009 study). Hence, there is no peptidoglycan flux prediction for NCTC 8325 due to a lack of input enzyme activities. However, we have two independent experimental datasets to validate the positive metabolic effects of PknB for peptidoglycan synthesis, and our NewHG microarray data support these flux predictions as well as the interactome data (
Table 1,
Table 2 and
Table 3) [
9]. One limitation of the study is that the proposed role of GlmR is based on theoretical predictions from this study and published data from other Gram-positive bacteria. However, phosphorylation of GlmR by PknB in vivo has not been proven yet and remains to be validated in future work.